Resumen

MARTIN-ECHEVARRIA, E. et al. Assessing the use of proton pump inhibitors in an internal medicine department. Rev. esp. enferm. dig. [online]. 2008, vol.100, n.2, pp.76-81. ISSN 1130-0108.

Introduction: proton pump inhibitors (PPIs) block the H⁺/K⁺ ATPase enzyme in gastric wall cells, leading to an inhibition of both baseline and stimulated acid secretion. Appropriate indications include: Gastroesophageal reflux, acute upper gastrointestinal bleeding, erosive gastritis or esophagitis, dyspepsia, NSAID-related gastropathy, and stress ulcer prophylaxis in high risk patients. The aims of this study were to review the current indications of PPIs, and to evaluate their use in Guadalajara's University Hospital. Material and methods: a transversal, analytic, randomized study was carried out during 2003 in our internal medicine department. A total of 208 medical records for 832 patients receiving PPIs were reviewed (25%). Mean age was 67 years (range: 16-92), 46.2% were females, and most frequent conditions were HBP, COPD, and DM. Results: 34.6% of patients took PPIs before admission, their use being inappropriate in 68.1% of them. Among hospitalized patients 73.03% used PPIs inappropriately, and most of them had no such indication at discharge. Conclusions: results are in accordance with the literature, with a high frequency of incorrect PPI use; a more accurate use of PPIs is to be recommended to avoid side effects and drug interactions, and to provide a more efficient medical care.

Palabras clave : Proton pump inhibitors; Indications; Guidelines; Overuse.

        · resumen en Español     · texto en Español     · Español ( pdf )